Biotech

All Articles

ReNeuron leaving behind AIM substitution after overlooking fundraising objective

.ReNeuron has participated in the long checklist of biotechs to leave Greater london's intention sto...

MBX files for IPO to take opposition to Ascendis in to stage 3

.MBX Biosciences has added to the recent spurt of IPO filings. The biotech, which filed its paperwor...

FDA grows probe right into Lykos' MDMA trials: WSJ

.For Lykos Therapies and also the provider's prospective MDMA-assisted therapy for post-traumatic st...

Gene publisher Tome giving up 131 workers

.Only days after genetics publisher Volume Biosciences revealed confidential operational slices, a m...

Repare gives up 25% of staff as biotech halts preclinical R&ampD

.Repare Rehab is giving up a quarter of its own workforce as the oncology biotech downsize its precl...

J &amp J apply for FDA confirmation of $6.5 B autoimmune medication

.Johnson &amp Johnson has taken another step towards recognizing a profit on its own $6.5 billion ni...

Gain's phase 1 succeed paves way to show Parkinson's medicine's worth

.Gain Therapeutics has actually established its own direct proving the effectiveness of its Parkinso...

Actinogen records brand-new stage 2 information to salvage clinical depression medicine

.Actinogen Medical's hopes-- and supply price-- have recoiled somewhat coming from earlier this mont...

Pfizer and Front runner incorporate Quotient to multibillion-dollar formula

.Crown Jewel Pioneering and also Pfizer have actually added Quotient right into their 10-program par...

Bayer pens $547M contract to push borders of noncoding RNA

.Bayer executives were eager to stress and anxiety to Ferocious this summer months that the German p...